{{Rsnum
|rsid=11958404
|Gene=MARK2P11
|Chromosome=5
|position=157983270
|Orientation=plus
|GMAF=0.08678
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;T)
| geno3=(T;T)
| CEU | 81.0 | 17.2 | 1.7
| HCB | 100.0 | 0.0 | 0.0
| JPT | 97.7 | 2.3 | 0.0
| YRI | 60.7 | 37.5 | 1.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23382691
  |Trait=IgG glycosylation
  |Title=Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.
  |RiskAllele=T
  |Pval=1E-6
  |OR=.25
  |ORtxt=[0.15-0.35] unit increase
  |OA=1
}}